Timothy Spelman

Galactomannan and PCR versus culture and histology for directing use of antifungal treatment for invasive aspergillosis in high-risk haematology patients: a randomised controlled trial

C. Orla Morrissey, Sharon C.‐A. Chen, Tania C. Sorrell et al. · The Lancet Infectious Diseases · 2013 · 219 citations

Invasive Aspergillosis, Antifungal Agent, Antifungal Agents +6

Sex as a determinant of relapse incidence and progressive course of multiple sclerosis

Tomáš Kalinčík, V. Vivek, Vilija Jokubaitis et al. · Brain · 2013 · 186 citations · Full text

Greater sensitivity to multiple sclerosis disability worsening and progression events using a roving versus a fixed reference value in a prospective cohort study

Ludwig Kappos, Helmut Butzkueven, Heinz Wiendl et al. · Multiple Sclerosis Journal · 2017 · 141 citations · Full text

Persistence on Therapy and Propensity Matched Outcome Comparison of Two Subcutaneous Interferon Beta 1a Dosages for Multiple Sclerosis

Tomáš Kalinčík, Timothy Spelman, María Trojano et al. · PLoS ONE · 2013 · 129 citations · Full text

High incidence of hepatitis C virus reinfection in a cohort of injecting drug users

Campbell Aitken, Jennifer A. Lewis, Samantha Tracy et al. · Hepatology · 2008 · 128 citations · Full text